Correlation Between Visa and CG Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and CG Oncology, Common, you can compare the effects of market volatilities on Visa and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and CG Oncology,.

Diversification Opportunities for Visa and CG Oncology,

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Visa and CGON is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Visa i.e., Visa and CG Oncology, go up and down completely randomly.

Pair Corralation between Visa and CG Oncology,

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.26 times more return on investment than CG Oncology,. However, Visa Class A is 3.91 times less risky than CG Oncology,. It trades about 0.1 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.01 per unit of risk. If you would invest  22,097  in Visa Class A on September 1, 2024 and sell it today you would earn a total of  9,411  from holding Visa Class A or generate 42.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy58.06%
ValuesDaily Returns

Visa Class A  vs.  CG Oncology, Common

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
CG Oncology, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CG Oncology, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CG Oncology, is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Visa and CG Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and CG Oncology,

The main advantage of trading using opposite Visa and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.
The idea behind Visa Class A and CG Oncology, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets